XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
 9 Months Ended
Mar. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity with respect to Company-issued stock options since June 28, 2024:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as of March 28, 2025
Outstanding at June 28, 2024934 $12.71 $45.00 — 
Granted— — 
Exercised— — 
Canceled— — 
Outstanding at March 28, 2025934 12.71 45.00 2.98 years— 
Exercisable at March 28, 2025— $— $— — — 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 28, 2024:
 Non-vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Outstanding at June 28, 20241,526 $41.35 
Granted902 39.93 
Vested(394)44.22 
Forfeited(164)42.04 
Outstanding at March 28, 20251,870 $39.36 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Loss:

 Third Quarters EndedNine Months Ended
 March 28, 2025March 29, 2024March 28, 2025March 29, 2024
Cost of revenues$813 $1,299 $759 $2,119 
Selling, general and administrative6,228 4,123 17,156 11,626 
Research and development1,507 1,498 4,687 4,678 
Stock-based compensation expense before tax8,548 6,920 22,602 18,423 
Income taxes(1)
(2,308)(1,868)(6,103)(4,974)
Stock-based compensation expense, net of income taxes$6,240 $5,052 $16,499 $13,449 
(1) Federal and state statutory rate of 27%